Innovative Solutions for Ethylene Oxide Mitigation Used in Sterilization Processes (Direct to Phase II)
ID: DHA244-D002Type: BOTH
Overview

Topic

Innovative Solutions for Ethylene Oxide Mitigation Used in Sterilization Processes (Direct to Phase II)

Agency

Department of DefenseN/A

Program

Type: SBIRPhase: BOTHYear: 2024
Timeline
  1. 1
    Release Oct 3, 2023 12:00 AM
  2. 2
    Open Oct 3, 2023 12:00 AM
  3. 3
    Next Submission Due Mar 31, 2025 12:00 AM
  4. 4
    Close Mar 31, 2025 12:00 AM
Description

The Department of Defense (DOD) is seeking proposals for innovative solutions to mitigate ethylene oxide (ETO) used in sterilization processes. The goal is to promote environmentally friendly and sustainable practices in the field of sterilization technologies. ETO is commonly used in the manufacturing of medical devices for its effective sterilization properties, but its use raises environmental and health concerns due to its potential carcinogenicity. The DOD is specifically looking for advancements in sterilization technologies that prioritize environmental sustainability and health by minimizing or eliminating ethylene oxide emissions during medical device sterilization. The technology should be compatible with current ETO sterilization equipment and processes, and should not require significant alterations to existing setups. The proposal should include a plan for FDA clearance and EPA review, and the technology should be operable with little training or background. The project will have a Phase I feasibility study followed by a Phase II development and refinement of the solution. The Phase II focus includes prototype development, efficacy testing, regulatory compliance, and a scale-up strategy or commercialization plan. The ultimate goal is to transition the ETO mitigation solution into widespread implementation across diverse industries, including medical, pharmaceutical, food, laboratory, veterinary, cosmetic, and textile sectors. The small business should have plans to secure funding from non-SBIR government sources and/or the private sector to develop or transition the prototypes into a viable product for sale to the military and/or commercial markets. The successful implementation of the ETO mitigation solution will contribute to a safer and more sustainable future for medical device manufacturing.

Files
No associated files provided.
Similar Opportunities
DOD SBIR 24.4 Annual - Innovative Solutions for Ethylene Oxide Mitigation Used in Sterilization Processes (Direct to Phase II)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for innovative solutions to mitigate ethylene oxide (ETO) used in sterilization processes. The goal is to promote environmentally friendly and sustainable practices in the field of sterilization technologies. ETO is commonly used in the manufacturing of medical devices for its effective sterilization properties, but its use raises environmental and health concerns due to its potential carcinogenicity. The DOD is specifically looking for advancements in sterilization technologies that prioritize environmental sustainability and health by minimizing or eliminating ethylene oxide emissions during medical device sterilization. The technology should be compatible with current ETO sterilization equipment and processes, and should not require significant alterations to existing setups. The proposal should include a plan for FDA clearance and EPA review, and the technology should be operable with little training or background. The project will have a Phase I feasibility study followed by a Phase II development and refinement of the solution. The Phase II focus includes prototype development, efficacy testing, regulatory compliance, and a scale-up strategy or commercialization plan. The ultimate goal is to transition the ETO mitigation solution into widespread implementation across diverse industries, including medical, pharmaceutical, food, laboratory, veterinary, cosmetic, and textile sectors. The small business should have plans to secure funding from non-SBIR government sources and/or the private sector to develop or transition the prototypes into a viable product for sale to the military and/or commercial markets. The successful implementation of the ETO mitigation solution will contribute to a safer and more sustainable future for medical device manufacturing.
DOD SBIR 24.4 Annual - Dynamic Synthetic Tissues for Medical Simulation and Training
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of dynamic synthetic tissues for medical simulation and training. The objective is to create material-based solutions that can accurately demonstrate prolonged casualty care, nursing care, and trauma scenarios by dynamically changing the patient state based on the care being provided. The synthetic tissue materials should be capable of emulating real medical complications and demonstrate changes in appearance over time, providing learners with the correct sensory cues for treatment. The targeted material response areas include color change, texture change, swelling/edema, liquid secretion, smell production, and temperature control. The project will be conducted in two phases. Phase I will focus on the feasibility of developing synthetic materials capable of dynamic change over time. The proposer will demonstrate a functional prototype incorporating at least two of the objective capabilities mentioned above. Phase II will build upon the Phase I findings and prototype, aiming to develop a well-defined prototype that meets the requirements of the topic and can be made commercially viable. The Phase II prototype should include tissues surrounding the wounded area and demonstrate at least three of the identified requirements. The project duration for Phase II is two years, with a funding amount of $1.1 million. The end-state of the project is to provide training tools for combat medic schoolhouses, nursing providers, and surgical training providers. The transition and commercialization process in Phase III will involve building additional wounds and surrounding tissues based on feedback and results from Phase II. Overall, this solicitation seeks innovative research and development in the field of dynamic synthetic tissues for medical simulation and training, with the goal of improving training immersion, realism, and soldier buy-in while enabling new training scenarios in prolonged casualty care.
DOD SBIR 24.4 Annual - Water Tester at Point of Need
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for a water tester at the point of need. The objective of this solicitation is to develop applied research for an innovative capability to improve water surveillance in field conditions. The goal is to create a rugged and compact field instrument that can provide microbiological and metal detection capabilities to reduce health risks to personnel. The water tester should be able to analyze for total coliforms, Escherichia coli, arsenic, lead, copper, and cyanide, providing rapid results within 4 hours. The equipment must be compact, durable, and able to fit in carry-on luggage, weighing no more than 25 pounds. The project will be conducted in two phases: Phase I involves a feasibility study, and Phase II focuses on developing and demonstrating a prototype system. The potential applications of this technology include military use, environmental programs, emergency response teams, and other federal directorates. The deadline for proposal submission is March 31, 2025. For more information, visit the solicitation link: [here](https://www.sbir.gov/node/2484467).
DOD SBIR 24.4 Annual - Water Tester at Point of Need
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of a water tester at the point of need. The objective of this research topic is to improve water surveillance by developing a rugged and compact field instrument capable of providing microbiological and metal detection capabilities. The goal is to reduce both short- and long-term health risks to personnel. The water tester should be able to analyze for total coliforms, Escherichia coli, arsenic, lead, copper, and cyanide, providing rapid results in less than 4 hours. The equipment must be compact, durable, and able to fit in a carry-on piece of luggage, weighing no more than 25 pounds. The project will be conducted in two phases: Phase I involves a feasibility study, while Phase II focuses on developing and demonstrating a prototype system. The potential applications of this technology include military use for Special Operations Forces and conventional forces, as well as environmental programs, emergency response teams, and other federal directorates. The project duration is not specified, but the solicitation is open until March 31, 2025. For more information, visit the DOD SBIR 24.4 Annual solicitation on grants.gov.
DOD SBIR 24.4 Annual - Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for a Small Business Innovation Research (SBIR) program focused on the topic of "Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)". The Defense Health Agency is the specific branch of the DOD overseeing this topic. The objective is to develop a simple-to-use sample collection and processing method that can accurately detect specific fungal and bacterial species commonly associated with complex battlefield wound infections. The technology should be capable of preparing an adequate specimen for identification and detection in far-forward deployed environments. The current diagnostic capabilities for battlefield wound infections are limited and time-consuming, leading to delays in treatment and medical intervention decisions. The proposed technology should provide rapid diagnostics with a sample collection-to-result time of less than 2 hours, improving patient outcomes and reducing morbidity and mortality. The technology should be compatible with wet/dry environments, require minimum logistical support, and be stable in long-term storage. It should also be easy to use with little training and provide unambiguous primary output. The technology must include a plan for FDA clearance and should align with CLIA-waived complexity standards. The SBIR program consists of three phases: Phase I focuses on demonstrating scientific and technical feasibility, Phase II involves refining the technology and integrating it with a rapid diagnostic platform, and Phase III aims to secure FDA approval and commercialize the technology for both civilian and military settings. The government may propose further harmonization of the technology with other relevant products to meet additional DoD requirements. The solicitation is open until March 31, 2025. More information can be found on the grants.gov website or the DOD SBIR/STTR Opportunities page.